tiprankstipranks
Advertisement
Advertisement

GB:AZN Stock Latest News

Oppenheimer biotech analysts hold an analyst/industry conference call
The FlyOppenheimer biotech analysts hold an analyst/industry conference call
1m ago
AZN
IONS
AstraZeneca Targets Pediatric Asthma Gains With New Glycopyrronium Trial
PremiumCompany Announcements
AstraZeneca Targets Pediatric Asthma Gains With New Glycopyrronium Trial
1h ago
AZN
AstraZeneca Advances Off‑the‑Shelf CAR‑T Program in Tough‑to‑Treat Multiple Myeloma
PremiumCompany Announcements
AstraZeneca Advances Off‑the‑Shelf CAR‑T Program in Tough‑to‑Treat Multiple Myeloma
1h ago
AZN
AstraZeneca’s CREW Study: Real-World Tezspire Data That Could Shape Respiratory Revenues
PremiumCompany Announcements
AstraZeneca’s CREW Study: Real-World Tezspire Data That Could Shape Respiratory Revenues
2h ago
AZN
Amgen, AstraZeneca announce Crossing trial showed ‘meaningful’ improvements
PremiumThe Fly
Amgen, AstraZeneca announce Crossing trial showed ‘meaningful’ improvements
7h ago
AZN
AMGN
Amgen, AstraZeneca report CROSSING trial met co-primary and secondary endpoints
PremiumThe FlyAmgen, AstraZeneca report CROSSING trial met co-primary and secondary endpoints
9h ago
AZN
AMGN
AstraZeneca’s Tezspire Hits Key Phase III Goals in Eosinophilic Esophagitis
Premium
Company Announcements
AstraZeneca’s Tezspire Hits Key Phase III Goals in Eosinophilic Esophagitis
12h ago
AZN
AstraZeneca Explores Eye Imaging to Spot Hidden Heart Disease: What Investors Should Watch
Premium
Company Announcements
AstraZeneca Explores Eye Imaging to Spot Hidden Heart Disease: What Investors Should Watch
1d ago
AZN
AstraZeneca, Daiichi’s TROPION-Urothelial04 phase 3 trial of Datroway initiated
PremiumThe Fly
AstraZeneca, Daiichi’s TROPION-Urothelial04 phase 3 trial of Datroway initiated
1d ago
AZN
AstraZeneca Deepens Its Type 2 Diabetes Pipeline With New Global Patient Mapping Study
PremiumCompany Announcements
AstraZeneca Deepens Its Type 2 Diabetes Pipeline With New Global Patient Mapping Study
2d ago
AZN
AstraZeneca Prices €2.55 Billion Eurobond to Support Long-Term Funding Strategy
PremiumCompany Announcements
AstraZeneca Prices €2.55 Billion Eurobond to Support Long-Term Funding Strategy
2d ago
AZN
AstraZeneca’s AZD4144 Interaction Study Adds Quiet Support to AZN’s Pipeline Story
PremiumCompany Announcements
AstraZeneca’s AZD4144 Interaction Study Adds Quiet Support to AZN’s Pipeline Story
3d ago
AZN
AstraZeneca initiated with an Outperform at CICC
PremiumThe FlyAstraZeneca initiated with an Outperform at CICC
3d ago
AZN
AstraZeneca initiated with an Outperform at CICC
Premium
The Fly
AstraZeneca initiated with an Outperform at CICC
4d ago
AZN
AstraZeneca’s EMBOLD-Asia Trial Signals Fresh Push Into Obesity Market
Premium
Company Announcements
AstraZeneca’s EMBOLD-Asia Trial Signals Fresh Push Into Obesity Market
7d ago
AZN
AstraZeneca’s SELENE 3 Trial Targets Extra Weight-Loss Upside for AZN Investors
PremiumCompany Announcements
AstraZeneca’s SELENE 3 Trial Targets Extra Weight-Loss Upside for AZN Investors
7d ago
AZN
AstraZeneca Expands Respiratory Pipeline With New China Trial for Chronic Lung Infections
PremiumCompany Announcements
AstraZeneca Expands Respiratory Pipeline With New China Trial for Chronic Lung Infections
8d ago
AZN
AstraZeneca CFO Receives First Vesting Under Long-Term Performance Share Plan
PremiumCompany Announcements
AstraZeneca CFO Receives First Vesting Under Long-Term Performance Share Plan
8d ago
AZN
AstraZeneca Tracks Real‑World Ultomiris Outcomes in Polish Rare Disease Study
PremiumCompany Announcements
AstraZeneca Tracks Real‑World Ultomiris Outcomes in Polish Rare Disease Study
9d ago
AZN
AstraZeneca to discontinue eVOLVE-Lung02 Phase III trial
PremiumThe FlyAstraZeneca to discontinue eVOLVE-Lung02 Phase III trial
10d ago
AZN
AstraZeneca announces results from DESTINY-Lung04 trial of Enhertu
Premium
The Fly
AstraZeneca announces results from DESTINY-Lung04 trial of Enhertu
10d ago
AZN
AstraZeneca announces results from Phase III trial of Tagrisso, savolitinib
Premium
The Fly
AstraZeneca announces results from Phase III trial of Tagrisso, savolitinib
10d ago
AZN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >